Skip to main content
  1. Market Insights
  2. Health
  3. Pharmacies
  4. OTC Products

Digestive & Intestinal Remedies (Pharmacies) - Sweden

Sweden
  • Revenue in the Digestives & Intestinal Remedies market is projected to reach US$49.75m in 2025.
  • Revenue is expected to show an annual growth rate (CAGR 2025-2029) of 0.50%, resulting in a market volume of US$50.75m by 2029.
  • In global comparison, most revenue will be generated China (US$3.41bn in 2025).
  • In relation to total population figures, per person revenues of US$4.63 are generated in 2025.

"

Definition:
The Digestives and Intestinal Remedies market encompasses a range of over-the-counter (OTC) natural and synthetic digestive agents and remedies designed to address gastrointestinal concerns. These products are available through pharmacies and are provided in various forms such as pills, powder, capsules, liquids, solutions, suspensions, drops, and suppositories. The market excludes prescription medications, substances contravening state regulations, or items not explicitly categorized as digestive medications (e.g., pain relievers). Notable among the best-selling products in this category are Perenterol, Iberogast, Dulcolax, and Buscopan Plus. This market exclusively covers product sales through pharmacies.

Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

"
In-Scope
  • Natural and synthetic agents
  • Digestive medicines
  • Remedies against gastrointestinal complaints
Out-Of-Scope
  • Prescription medicines
  • Homeopathic remedies
  • Tea
OTC Products: market data & analysis - Cover

Market Insights report

OTC Products: market data & analysis
Study Details

    Revenue

    Notes: Data was converted from local currencies using average exchange rates of the respective year.

    Most recent update:

    Source: Statista Market Insights

    Most recent update:

    Source: Statista Market Insights

    Most recent update:

    Source: Statista Market Insights

    Analyst Opinion

    The Digestive & Intestinal Remedies (Pharmacies) market in Sweden is experiencing steady growth due to changing customer preferences, emerging trends in the market, and local special circumstances.

    Customer preferences:
    Customers in Sweden are increasingly seeking natural and organic remedies for digestive and intestinal issues. They are more conscious about the ingredients used in these remedies and prefer products that are free from artificial additives and preservatives. This shift towards natural remedies is driven by a growing awareness of the potential side effects of traditional medications and a desire for more holistic approaches to healthcare.

    Trends in the market:
    One of the key trends in the Digestive & Intestinal Remedies market in Sweden is the rising demand for probiotics. Probiotics are beneficial bacteria that promote a healthy digestive system. They are commonly found in fermented foods and supplements. The popularity of probiotics can be attributed to the growing interest in gut health and its impact on overall well-being. Consumers are increasingly turning to probiotic supplements to improve digestion and boost their immune system. Another trend in the market is the increasing availability of over-the-counter (OTC) digestive remedies. Previously, many digestive and intestinal remedies required a prescription. However, there has been a shift towards making these products more accessible to consumers without the need for a doctor's visit. This has led to an increase in the variety of OTC options available in pharmacies, making it easier for customers to find the right product for their needs.

    Local special circumstances:
    Sweden has a high rate of lactose intolerance, with a significant portion of the population unable to digest lactose, the sugar found in milk and dairy products. This has led to a greater demand for lactose-free digestive remedies in the market. Pharmacies in Sweden often stock a wide range of lactose-free products to cater to the needs of lactose-intolerant customers.

    Underlying macroeconomic factors:
    The growing Digestive & Intestinal Remedies market in Sweden is also influenced by underlying macroeconomic factors. The country has a high standard of living and a well-developed healthcare system, which allows consumers to prioritize their health and well-being. Additionally, Sweden has a strong focus on preventive healthcare, with a high level of awareness about the importance of maintaining a healthy lifestyle. This has contributed to the increasing demand for digestive and intestinal remedies as consumers take proactive steps to manage their digestive health. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Sweden is driven by changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. The demand for natural and organic remedies, the popularity of probiotics, the availability of OTC options, the prevalence of lactose intolerance, and the country's focus on preventive healthcare all contribute to the growth of this market.

    Global Comparison

    Most recent update:

    Source: Statista Market Insights

    Methodology

    Data coverage:

    The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

    Modeling approach:

    Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

    Forecasts:

    In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

    Additional notes:

    The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

    Health

    Access more Market Insights on Health topics with our featured report

    OTC Products: market data & analysis - BackgroundOTC Products: market data & analysis - Cover

    Explore more high-quality data on related topic

    Pharma e-commerce – statistics & facts

    The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.
    More data on the topic

    Contact

    Get in touch with us. We are happy to help.
    Meredith Alda
    Sales Manager

    Mon - Fri, 9am - 6pm (EST)

    Lodovica Biagi
    Director of Operations

    Mon - Fri, 9:30am - 5pm (GMT)

    Ayana Mizuno
    Junior Business Development Manager

    Mon - Fri, 10:00am - 6:00pm (JST)

    Carolina Dulin
    Group Director - LATAM

    Mon - Fri, 9am - 6pm (EST)

    Yolanda Mega
    Operations Manager

    Mon - Fri, 9am - 5pm (SGT)